US Patent
US9278182 — Devices, systems and methods for medicament delivery
Formulation · Assigned to kaleo Inc · Expires 2026-02-01 · 0y expired
Vulnerability score
45/100
Strong — defensible against typical IPR challenges
What this patent protects
This patent protects a label for a medicament delivery device that includes a textual indicia and an electronic circuit system.
USPTO Abstract
An apparatus includes a label configured to be coupled to a medicament delivery device. The label includes a first surface and a second surface. The first surface is configured to be coupled to an outer surface of the medicament delivery device. The second surface includes a textual indicia. The label further includes an electronic circuit system configured to output an electronic signal.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.